Corona Remedies Ltd

Corona Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Corona Remedies Ltd

₹ 1,450 2.13%
28 Jan - close price
Company website BSE: 544644 NSE: CORONA
About
[ add key points ]
Website BSE NSE
  • Market Cap ₹ 8,873 Cr.
  • Current Price ₹ 1,450
  • High / Low ₹ 1,541 / 1,337
  • Stock P/E 55.9
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 31.5 %
  • ROE 27.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 20.4% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 25.0%

Cons

  • Promoter holding has decreased over last quarter: -3.50%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2024 Jun 2025 Sep 2025
314 347 361
247 277 283
Operating Profit 67 70 78
OPM % 21% 20% 22%
2 2 2
Interest 3 2 2
Depreciation 9 9 9
Profit before tax 57 61 70
Tax % 25% 24% 25%
43 46 52
EPS in Rs 7.03 7.59 8.53
Raw PDF
Upcoming result date: 2 February 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
509 601 576 617 884 1,014 1,196
444 509 471 600 756 859 956
Operating Profit 66 93 105 18 128 156 241
OPM % 13% 15% 18% 3% 14% 15% 20%
3 3 5 7 7 5 5
Interest 1 2 2 5 4 14 11
Depreciation 14 16 16 20 20 28 37
Profit before tax 54 77 92 -1 111 118 198
Tax % 35% 24% 24% -49% 23% 24% 25%
35 59 70 -0 85 90 149
EPS in Rs 74.85 126.70 150.72 -0.08 13.85 14.80 24.37
Dividend Payout % 0% 0% 0% 0% 20% 25% 30%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 25%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: 20%
3 Years: 538%
TTM: 64%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 24%
Last Year: 28%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5 5 5 51 61 61 61 61
Reserves 204 263 333 270 347 419 545 598
13 47 50 34 28 159 86 63
71 94 144 157 159 191 237 254
Total Liabilities 293 408 532 511 595 830 929 976
80 81 164 162 185 384 370 368
CWIP 4 42 0 14 65 121 186 205
Investments 9 7 37 14 31 25 25 25
200 278 330 321 314 301 348 378
Total Assets 293 408 532 511 595 830 929 976

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
19 43 79 98 103 157 190
-23 -50 -102 -66 -50 -267 -84
4 30 0 -30 -45 99 -107
Net Cash Flow -1 23 -23 2 8 -11 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 95 105 131 44 36 36 36
Inventory Days 69 52 77 184 182 158 200
Days Payable 126 110 182 211 163 184 221
Cash Conversion Cycle 38 48 27 17 55 10 14
Working Capital Days 67 81 86 16 30 -2 9
ROCE % 30% 27% 1% 29% 25% 31%

Shareholding Pattern

Numbers in percentages

6 Recently
Dec 2025
69.00%
1.84%
6.77%
22.41%
No. of Shareholders 31,035

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP

Concalls